A phase 2 study of efficacy and safety of tislelizumab plus chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma
Latest Information Update: 07 Jul 2023
At a glance
- Drugs Tislelizumab (Primary) ; Carboplatin; Cisplatin; Docetaxel
- Indications Oesophageal cancer
- Focus Therapeutic Use
Most Recent Events
- 07 Jul 2023 New trial record
- 06 Jun 2023 Interim Results (n=28) presented at the 59th Annual Meeting of the American Society of Clinical Oncology.